The U.S. Army Medical Command awarded a single-award indefinite-delivery/indefinite-quantity contract to Laboratory Corporation of America with a potential value of $204,639,688.42 to provide clinical reference laboratory testing services at multiple military treatment facilities located within the continental United States and overseas. The contract's period of performance spans from January 1, 2021 through December 31, 2025. Delivery orders issued against the contract by the Army Medical Command call for Laboratory Corporation of America to perform diagnostic analysis and anatomical pathology testing at installations such as Madigan Army Medical Center, Tripler Army Medical Center, and Bassett Army Community Hospital to support patient care services. The Special Notice published by the Army Medical Command sought industry feedback on a draft request for proposal to procure these clinical laboratory testing services in order to improve the solicitation's clarity and completeness prior to its formal release.
The Defense Health Agency subsequently awarded multiple firm-fixed-price delivery orders against the REFERENCE LAB contract to Laboratory Corporation of America totaling over $30 million. The delivery orders have periods of performance ranging from October 2023 through September 2024 and October 2023 through March 2024. They require Laboratory Corporation of America to provide reference laboratory testing services to military treatment facilities located in various states and overseas locations such as Hawaii, Alaska, Washington, and Japan. The services aim to support the Defense Health Agency's management of the Military Health System including healthcare delivery and medical research programs.
Generated 1/4/24, 10:45 PM